Global Smoking Cessation and Nicotine De-Addiction Market, By Product Type (Nicotine Replacement Therapy Products, Nicotine Lozenges, Nicotine Gums, Nicotine Sprays, Nicotine Transdermal Patches, Drug Therapy, Zyban, Chantix, Nicotine Sublingual Tablets, Nicotine Inhalers, E-cigarettes), Type (Pharmacological, Therapies and Others), Distribution Channel (Online, Offline), End-User (Generation Z, Millennials, Generation X and Silent Generation), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Smoking Cessation and Nicotine De-Addiction Market
The smoking cessation and nicotine de-addiction market is expected to witness market growth at a rate of 15.4% in the forecast period of 2021 to 2028. Data Bridge Market Research report on smoking cessation and nicotine de-addiction market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. Rapid urbanization is escalating the growth of smoking cessation and nicotine de-addiction market.
Smoking cessation or nicotine de-addiction comprises of tobacco discontinuation. Tobacco is known to contain nicotine that causes addiction by releasing neurotransmitters such as dopamine, gamma-aminobutyric acid (GABA) and glutamate. Smoking cessation products is highly beneficial in treating cigarette and tobacco addicts.
The rise in the number of people trying to quit smoking across the globe acts as one of the major factors driving the growth of smoking cessation and nicotine de-addiction market. Government is emphasizing strict regulations to control the nicotine and cigarette addiction due to its toxic effects on cardiac and respiratory systems, and high taxes on tobacco products accelerate the market growth. The increase in the government policies in relation to smoking cessation include smoking prohibition in public places and growth in awareness regarding ill effects of smoking among population further influence the market. Additionally, high adoption of ill lifestyle options, rapid urbanization and surge in disposable income positively affect the smoking cessation and nicotine de-addiction market. Furthermore, government initiatives to promote awareness extend profitable opportunities to the market players in the forecast period of 2021 to 2028.
On the other hand, reluctance in accepting the treatment is expected to obstruct the market growth. Lack of awareness is projected to challenge the smoking cessation and nicotine de-addiction market in the forecast period of 2021-2028.
This smoking cessation and nicotine de-addiction market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on smoking cessation and nicotine de-addiction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Smoking Cessation and Nicotine De-Addiction Market Scope and Market Size
The smoking cessation and nicotine de-addiction market is segmented on the basis of product type, type and end-user. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of product type, the smoking cessation and nicotine de-addiction market is segmented into nicotine replacement therapy products, nicotine lozenges, nicotine gums, nicotine sprays, nicotine transdermal patches, drug therapy, zyban, chantix, nicotine sublingual tablets, nicotine inhalers and e-cigarettes.
- On the basis of type, the smoking cessation and nicotine de-addiction market is segmented into pharmacological, therapies and others.
- On the basis of end-user, the smoking cessation and nicotine de-addiction market is segmented into generation z, millennials, generation x and silent generation.
Global Smoking Cessation and Nicotine De-Addiction Market Country Level Analysis
The smoking cessation and nicotine de-addiction market is analyzed and market size, volume information is provided by country, product type, type and end user as referenced above.
The countries covered in the global smoking cessation and nicotine de-addiction market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates smoking cessation and nicotine de-addiction market due to the established healthcare infrastructure and high disposable income within the region. Asia-Pacific region is expected to witness lucrative growth during the forecast period of 2021 to 2028 because of the high economic growth in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Smoking Cessation and Nicotine De-Addiction Market Share Analysis
The smoking cessation and nicotine de-addiction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to smoking cessation and nicotine de-addiction market.
The major players covered in the smoking cessation and nicotine de-addiction market reports are Cipla Inc., Johnson & Johnson Services, Inc., Takeda Consumer Healthcare Company Limited, Alkalon A/S, 22nd Century Group, Inc., GlaxoSmithKline plc., Imperial Brands, Japan Tobacco Inc., British American Tobacco, Perrigo Company plc, Fertin Pharma, Cambrex Corporation, Dr. Reddy’s Laboratories Ltd., Pfizer Inc. and Strides Pharma Science Limited, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand.
SKU-